Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.65
+1.31 (4.62%)
At close: Mar 9, 2026, 4:00 PM EDT
29.98
+0.33 (1.11%)
After-hours: Mar 9, 2026, 5:26 PM EDT
Viridian Therapeutics Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$41.17
Upside
+38.85%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +41.65% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +41.65% | Feb 4, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $26 → $29 | Hold | Maintains | $26 → $29 | -2.19% | Feb 3, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $41 → $40 | Strong Buy | Maintains | $41 → $40 | +34.91% | Jan 8, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +68.63% | Jan 7, 2026 |
| Needham | Needham | Strong Buy Maintains $34 → $42 | Strong Buy | Maintains | $34 → $42 | +41.65% | Dec 23, 2025 |
| Wedbush | Wedbush | Buy Maintains $42 → $47 | Buy | Maintains | $42 → $47 | +58.52% | Dec 10, 2025 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 3, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +38.28% | Nov 24, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $41 → $45 | Buy | Maintains | $41 → $45 | +51.77% | Nov 6, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $61 | Strong Buy | Reiterates | $61 | +105.73% | Nov 4, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $32 → $36 | Buy | Maintains | $32 → $36 | +21.42% | Oct 21, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +1.18% | Aug 7, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +38.28% | Aug 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | -12.31% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | +7.93% | Aug 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.